Severe tumor budding is a risk factor for lateral lymph node metastasis in early rectal cancers

Journal of Surgical Oncology

Volumn 102, Issue 3, 2010, Pages 230-234

  Homma, Yoichiro ^a   Hamano, Takashi ^a   Otsuki, Yoshiro ^a   Shimizu, Shinichi ^a   Kobayashi, Hiroshi ^a   Kobayashi, Yasuyuki ^a  

^a SEIREI HAMAMATSU GENERAL HOSPITAL   (Japan)

Author keywords

Early rectal cancer; Lateral lymph node metastasis; Tumor budding

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CELL MIGRATION; CLINICAL ARTICLE; EARLY CANCER; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MESENTERY LYMPH NODE; PRIORITY JOURNAL; RECTUM CARCINOMA; RISK FACTOR; TUMOR BUDDING; TUMOR GROWTH; TUMOR LOCALIZATION;

AGED; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77956381205     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21606     Document Type: Article

References (37)

1. Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet 1996;348:1610-1614.
2. Heald RJ, Ryall RD: Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1:1479-1482. (Pubitemid 16095660)
3. Hojo K, Koyama Y, Moriya Y: Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 1982;144:350-354. (Pubitemid 12032632)
4. Kim TH, Jeong SY, Choi DH, et al.: Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 2008;15:729-737.
5. Ueno M, Oya M, Azekura K, et al.: Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 2005;92:756-763. (Pubitemid 40863199)
6. Yano H, Moran BJ: The incidence of lateral pelvic side-wall nodal involvement in low rectal cancer may be similar in Japan and the West. Br J Surg 2008;95:33-49. (Pubitemid 351184913)
7. Heald RJ: Total mesorectal excision is optimal surgery for rectal cancer: A Scandinavian consensus. Br J Surg 1995;82:1297-1299.
8. Enker WE, Thaler HT, Cranor ML, et al.: Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995;181:335-346.
9. Cambray i Amenos M, Navarro Garcia M, Marti Rague J, et al.: Preoperative radio-chemotherapy (RT-CT) in rectal cancer. Prospective study with postoperative RT-CT control group. Clin Transl Oncol 2007;9:183-191.
10. Sugihara K, Kobayashi H, Kato T, et al.: Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 2006;49:1663-1672. (Pubitemid 44800483)
11. Kyo K, Sameshima S, Takahashi M, et al.: Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer. World J Surg 2006;30:1014-1019. (Pubitemid 43824412)
12. Guckenberger M, Flentje M: Late small bowel toxicity after adjuvant treatment for rectal cancer. Int J Colorectal Dis 2006;21:209-220. (Pubitemid 43280328)
13. Borschitz T, Wachtlin D, Mohler M, et al.: Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol 2008;15:712-720.
14. Bentrem DJ, Okabe S, Wong WD, et al.: T1 adenocarcinoma of the rectum: Transanal excision or radical surgery? Ann Surg 2005;242:472-477, discussion 477-479.
15. Ptok H, Marusch F, Meyer F, et al.: Oncological outcome of local vs radical resection of low-risk pT1 rectal cancer. Arch Surg 2007;142:649-655, discussion 656. (Pubitemid 47080444)
16. Endreseth BH, Myrvold HE, Romundstad P, et al.: Transanal excision vs. major surgery for T1 rectal cancer. Dis Colon Rectum 2005;48:1380-1388. (Pubitemid 40933865)
17. Bonadeo FA, Vaccaro CA, Benati ML, et al.: Rectal cancer: Local recurrence after surgery without radiotherapy. Dis Colon Rectum 2001;44:374-379. (Pubitemid 32226326)
18. Mori T, Takahashi K, Yamaguchi T, et al.: General rules for management of cancer of the colon and the rectum. Nippon Rinsho 2003;61:255-261.
19. Muto T, Kotake K, Koyama Y: Colorectal cancer statistics in Japan: Data from JSCCR registration, 1974-1993. Int J Clin Oncol 2001;6:171-176.
20. Kobayashi H, Mochizuki H, Sugihara K, et al.: Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: A multicenter study. Surgery 2007;141:67-75. (Pubitemid 44918081)
21. Kato T, Ohashi Y, Nakazato H, et al.: Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: Multicenter prospective randomized trial. Langenbecks Arch Surg 2002;386:575-581. (Pubitemid 34285637)
22. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-1450.
23. Nakfoor BM, Willett CG, Shellito PC, et al.: The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary rectal and rectosigmoid cancer. Ann Surg 1998;228:194-200.
24. Hase K, Shatney C, Johnson D, et al.: Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum 1993;36:627-635.
25. Ueno H, Mochizuki H, Hashiguchi Y, et al.: Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004;127:385-394. (Pubitemid 39091886)
26. Masaki T, Matsuoka H, Sugiyama M, et al.: Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas. J Gastroenterol Hepatol 2006;21:1115-1121. (Pubitemid 43910001)
27. Yano H, Saito Y, Takeshita E, et al.: Prediction of lateral pelvic node involvement in low rectal cancer by conventional computed tomography. Br J Surg 2007;94:1014-1019. (Pubitemid 47236548)
28. Kikuchi R, Takano M, Takagi K, et al.: Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 1995;38:1286-1295.
29. Gabbert H: Mechanisms of tumor invasion: Evidence from in vivo observations. Cancer Metastasis Rev 1985;4:293-309.
30. Ueno H, Murphy J, Jass JR, et al.: Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002;40:127-132.
31. Okuyama T, Oya M, Ishikawa H: Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum 2002;45:628-634. (Pubitemid 34507238)
32. Ueno H, Price AB, Wilkinson KH, et al.: A new prognostic staging system for rectal cancer. Ann Surg 2004;240:832-839. (Pubitemid 39425776)
33. Ueno H, Mochizuki H, Shinto E, et al.: Histologic indices in biopsy specimens for estimating the probability of extended local spread in patients with rectal carcinoma. Cancer 2002;94:2882-2891. (Pubitemid 34547687)
34. Valentini V, Beets-Tan R, Borras JM, et al.: Evidence and research in rectal cancer. Radiother Oncol 2008;87:449-474.
35. Stamos MJ, Murrell Z: Management of early rectal T1 and T2 cancers. Clin Cancer Res 2007;13:6885s-6889s.
36. Funahashi K, Koike J, Shimada M, et al.: A preliminary study of the draining lymph node basin in advanced lower rectal cancer using a radioactive tracer. Dis Colon Rectum 2006;49:S53-S58.
37. Sterk P, Keller L, Jochims H, et al.: Lymphoscintigraphy in patients with primary rectal cancer: The role of total mesorectal excision for primary rectal cancer - A lymphoscintigraphic study. Int J Colorectal Dis 2002;17:137-142, discussion 143.